X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs FRESENIUS KABI ONCO. - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD FRESENIUS KABI ONCO. WYETH LTD/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 27.7 22.1 125.3% View Chart
P/BV x 5.3 3.1 171.8% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    WYETH LTD
Mar-13
FRESENIUS KABI ONCO.
Mar-13
WYETH LTD/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs1,044176 593.4%   
Low Rs81879 1,042.0%   
Sales per share (Unadj.) Rs298.637.7 792.3%  
Earnings per share (Unadj.) Rs57.25.1 1,123.9%  
Cash flow per share (Unadj.) Rs58.46.7 868.8%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.542.5 586.4%  
Shares outstanding (eoy) m22.72158.23 14.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.4 92.4%   
Avg P/E ratio x16.325.0 65.1%  
P/CF ratio (eoy) x15.918.9 84.2%  
Price / Book Value ratio x3.73.0 124.8%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,15720,135 105.1%   
No. of employees `0000.51.2 42.7%   
Total wages/salary Rs m400703 56.9%   
Avg. sales/employee Rs Th13,787.45,176.2 266.4%   
Avg. wages/employee Rs Th813.0610.4 133.2%   
Avg. net profit/employee Rs Th2,643.3699.6 377.8%   
INCOME DATA
Net Sales Rs m6,7835,963 113.8%  
Other income Rs m35318 1,958.9%   
Total revenues Rs m7,1365,981 119.3%   
Gross profit Rs m1,6171,430 113.1%  
Depreciation Rs m27258 10.3%   
Interest Rs m6-26 -21.2%   
Profit before tax Rs m1,9381,216 159.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5-68 7.5%   
Tax Rs m632342 184.7%   
Profit after tax Rs m1,301806 161.4%  
Gross profit margin %23.824.0 99.4%  
Effective tax rate %32.628.1 115.9%   
Net profit margin %19.213.5 141.9%  
BALANCE SHEET DATA
Current assets Rs m6,9845,102 136.9%   
Current liabilities Rs m2,0562,385 86.2%   
Net working cap to sales %72.645.6 159.5%  
Current ratio x3.42.1 158.8%  
Inventory Days Days99150 66.2%  
Debtors Days Days24113 21.1%  
Net fixed assets Rs m2445,148 4.7%   
Share capital Rs m227158 143.6%   
"Free" reserves Rs m5,4416,556 83.0%   
Net worth Rs m5,6686,732 84.2%   
Long term debt Rs m25952 2.6%   
Total assets Rs m7,90110,388 76.1%  
Interest coverage x353.3-45.8 -771.8%   
Debt to equity ratio x00.1 3.1%  
Sales to assets ratio x0.90.6 149.6%   
Return on assets %16.57.5 220.2%  
Return on equity %22.912.0 191.7%  
Return on capital %34.014.6 233.1%  
Exports to sales %0.274.5 0.3%   
Imports to sales %36.324.8 146.7%   
Exports (fob) Rs m154,441 0.3%   
Imports (cif) Rs m2,4651,477 166.9%   
Fx inflow Rs m155,298 0.3%   
Fx outflow Rs m2,6771,772 151.1%   
Net fx Rs m-2,6623,525 -75.5%   
CASH FLOW
From Operations Rs m9231,274 72.5%  
From Investments Rs m317-1,204 -26.3%  
From Financial Activity Rs m-481-196 245.3%  
Net Cashflow Rs m759-126 -601.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 81.0 63.1%  
Indian inst/Mut Fund % 11.3 0.3 3,766.7%  
FIIs % 7.2 9.6 75.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 9.1 334.1%  
Shareholders   21,978 42,599 51.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS